CN109364175A - 一种用于缓解眼睛干涩的眼药水及其制备方法 - Google Patents
一种用于缓解眼睛干涩的眼药水及其制备方法 Download PDFInfo
- Publication number
- CN109364175A CN109364175A CN201811195761.1A CN201811195761A CN109364175A CN 109364175 A CN109364175 A CN 109364175A CN 201811195761 A CN201811195761 A CN 201811195761A CN 109364175 A CN109364175 A CN 109364175A
- Authority
- CN
- China
- Prior art keywords
- parts
- eyes
- astringent
- dry
- eyedrops
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003889 eye drop Substances 0.000 title claims abstract description 22
- 229940012356 eye drops Drugs 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000243 solution Substances 0.000 claims abstract description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 20
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 14
- 241001116389 Aloe Species 0.000 claims abstract description 12
- 241001113925 Buddleja Species 0.000 claims abstract description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 12
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 12
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000008223 sterile water Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 208000003464 asthenopia Diseases 0.000 abstract description 4
- 208000030533 eye disease Diseases 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 201000005111 ocular hyperemia Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液1‑20份、薄荷提取液20‑25份、枸杞叶80‑110、决明子80‑100份、密蒙花50‑70份、桑叶45‑60份、茺蔚子3‑5份、芦荟提取液30‑40份、维生素组合物0.1‑1份、氯化钠3‑10和水适量;本发明具有舒缓眼部视觉疲劳的效果,有效缓解眼睛干涩疲劳,预防眼部疾病的产生。
Description
技术领域
本发明涉及一种眼药水,具体涉及一种用于缓解眼睛干涩的眼药水及其制备方法。
背景技术
眼睛是人体最重要的器官之一,随着电子产品的出现和不断发展以及更新换代,人们日常接触电子屏幕的时间越来越长,由于长时间近距离使用电子屏幕,导致人们眼睛越来越多的出现问题,且在较长时间近距离用眼或者用眼不久后会出现视功能减退或一系列眼部不适,较为常见的就有视觉疲劳症、近视、眼睛干涩肿痛、眼睛灼热发红、眼眶疼痛,重者甚至会出现偏头痛、精神萎靡等症状,影响日常工作和学习。
所以,为解决上述问题,开发一种用于缓解眼睛干涩的眼药水及其制备方法很有必要。
发明内容
本发明的目的是为了克服现有技术的不足,而提供一种用于缓解眼睛干涩的眼药水及其制备方法,具有舒缓眼部视觉疲劳的效果,有效缓解眼睛干涩疲劳,预防眼部疾病的产生。
本发明的目的是这样实现的:一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液1-20份、薄荷提取液20-25份、枸杞叶80-110、决明子80-100份、密蒙花50-70份、桑叶45-60份、茺蔚子3-5份、芦荟提取液30-40份、维生素组合物0.1-1份、氯化钠3-10和水适量。
所述维生素组合物包括维生素A、维生素B2、维生素C和维生素E的其中一种或其组合物。
其中原料中所采用的水为无菌水。
一种用于缓解眼睛干涩的眼药水的制备方法,其制备方法包括以下步骤:
(1)取适量枸杞叶、决明子、密蒙花、桑叶和茺蔚子,进行消毒处理后放入无菌反应釜中,加入10-15倍的无菌水在25-35℃条件下浸泡1-2小时后,高温加热煮沸后转中温,此处中温可保持药液沸腾即可,熬煮3.5-4.5小时后,提取药液过滤后,得到滤液冷却至常温后备用。
(2)取适量珍珠粉水介液、薄荷提取液、芦荟提取液、维生素组合物和氯化钠,进行消毒处理后放入无菌搅拌釜中,加入5-8倍的无菌水,充分搅拌混合均匀10-12小时后,过滤得到滤液备用。
(3)将步骤(1)和步骤(2)所得到的滤液在无菌搅拌釜中搅拌混合均匀12-24小时,过滤得到滤液即为用于缓解眼睛干涩的眼药水。
所述步骤(1)、(2)、(3)中的反应均是在无菌条件下进行的。
所述步骤(1)和(2)中对各组分进行消毒处理所采用的消毒方式为射线消毒杀菌。
由于采用了上述技术方案,本发明的有益效果是:本发明中采用枸杞叶、决明子、密蒙花等中草药,具有养肝明目、缓解视力疲劳的效果,同时加入维生素组合物、珍珠水介液、薄荷提取液和芦荟提取液,可有效缓解眼部干涩不适,预防眼部疾病的产生。
具体实施方式
下面通过实施例,对本发明的技术方案做进一步具体的说明。
一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液1-20份、薄荷提取液20-25份、枸杞叶80-110、决明子80-100份、密蒙花50-70份、桑叶45-60份、茺蔚子3-5份、芦荟提取液30-40份、维生素组合物0.1-1份、氯化钠3-10和水适量。
所述维生素组合物包括维生素A、维生素B2、维生素C和维生素E的其中一种或其组合物。
其中原料中所采用的水为无菌水。
一种用于缓解眼睛干涩的眼药水的制备方法,其制备方法包括以下步骤:
(1)取适量枸杞叶、决明子、密蒙花、桑叶和茺蔚子,进行消毒处理后放入无菌反应釜中,加入10-15倍的无菌水在25-35℃条件下浸泡1-2小时后,高温加热煮沸后转中温,此处中温可保持药液沸腾即可,熬煮3.5-4.5小时后,提取药液过滤后,得到滤液冷却至常温后备用。
(2)取适量珍珠粉水介液、薄荷提取液、芦荟提取液、维生素组合物和氯化钠,进行消毒处理后放入无菌搅拌釜中,加入5-8倍的无菌水,充分搅拌混合均匀10-12小时后,过滤得到滤液备用。
(3)将步骤(1)和步骤(2)所得到的滤液在无菌搅拌釜中搅拌混合均匀12-24小时,过滤得到滤液即为用于缓解眼睛干涩的眼药水。
所述步骤(1)、(2)、(3)中的反应均是在无菌条件下进行的。
所述步骤(1)和(2)中对各组分进行消毒处理所采用的消毒方式为射线消毒杀菌。
其中,珍珠可清肝除翳明目,用治目赤肿痛、翳膜遮睛等眼科疾病;薄荷可清心明目;枸杞叶可清热明目;决明子具有清肝明目的功能;密蒙花有清热利湿、明目退翳之功效;桑叶有疏散风热、清肺润燥、清肝明目的功效;茺蔚子可用于目赤肿痛;芦荟有泻火解毒之功效;维生素A可预防夜盲症,视力衰退,治疗各种眼疾;维生素B2可增进视力,减轻眼睛的疲劳;维生素C可提高免疫力;维生素E可抑制眼睛晶状体内的过氧化脂反应,使末梢血管扩张,改善血液循环,预防近视眼发生和发展。
实施例一:
一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液10份、薄荷提取液20份、枸杞叶80、决明子80份、密蒙花50份、桑叶45份、茺蔚子3份、芦荟提取液30份、维生素组合物0.3份、氯化钠3和水适量;其制备方法如上所述。
实施例二:
一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液15份、薄荷提取液23份、枸杞叶100、决明子90份、密蒙花60份、桑叶50份、茺蔚子4份、芦荟提取液35份、维生素组合物0.5份、氯化钠5和水适量;其制备方法如上所述。
实施例三:
一种用于缓解眼睛干涩的眼药水,包括以下质量分数的各组分:珍珠粉水介液20份、薄荷提取液25份、枸杞叶110、决明子100份、密蒙花70份、桑叶60份、茺蔚子5份、芦荟提取液40份、维生素组合物1份、氯化钠10和水适量;其制备方法如上所述。
最后应说明的是,以上实施例仅用以说明本发明的技术方案,而非对其限制,尽管参照上述实施例对本发明进行了详细的说明,所属领域的普通技术人员应当理解,依然可以对本发明的具体实施方式进行修改或者等同替换,而未脱离本发明精神和范围的任何修改或者等同替换,其均应涵盖在本发明的权利要求范围当中。
Claims (6)
1.一种用于缓解眼睛干涩的眼药水,其特征在于:包括以下质量分数的各组分:珍珠粉水介液1-20份、薄荷提取液20-25份、枸杞叶80-110、决明子80-100份、密蒙花50-70份、桑叶45-60份、茺蔚子3-5份、芦荟提取液30-40份、维生素组合物0.1-1份、氯化钠3-10和水适量。
2.根据权利要求1所述的一种用于缓解眼睛干涩的眼药水,其特征在于:所述维生素组合物包括维生素A、维生素B2、维生素C和维生素E的其中一种或其组合物。
3.根据权利要求1所述的一种用于缓解眼睛干涩的眼药水,其特征在于:其中原料中所采用的水为无菌水。
4.一种用于缓解眼睛干涩的眼药水的制备方法,其特征在于:其制备方法包括以下步骤:
(1)取适量枸杞叶、决明子、密蒙花、桑叶和茺蔚子,进行消毒处理后放入无菌反应釜中,加入10-15倍的无菌水在25-35℃条件下浸泡1-2小时后,高温加热煮沸后转中温,此处中温可保持药液沸腾即可,熬煮3.5-4.5小时后,提取药液过滤后,得到滤液冷却至常温后备用;
(2)取适量珍珠粉水介液、薄荷提取液、芦荟提取液、维生素组合物和氯化钠,进行消毒处理后放入无菌搅拌釜中,加入5-8倍的无菌水,充分搅拌混合均匀10-12小时后,过滤得到滤液备用;
(3)将步骤(1)和步骤(2)所得到的滤液在无菌搅拌釜中搅拌混合均匀12-24小时,过滤得到滤液即为用于缓解眼睛干涩的眼药水。
5.根据权利要求1所述的一种用于缓解眼睛干涩的眼药水的制备方法,其特征在于:所述步骤(1)、(2)、(3)中的反应均是在无菌条件下进行的。
6.根据权利要求1所述的一种用于缓解眼睛干涩的眼药水的制备方法,其特征在于:所述步骤(1)和(2)中对各组分进行消毒处理所采用的消毒方式为射线消毒杀菌。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811195761.1A CN109364175A (zh) | 2018-10-15 | 2018-10-15 | 一种用于缓解眼睛干涩的眼药水及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811195761.1A CN109364175A (zh) | 2018-10-15 | 2018-10-15 | 一种用于缓解眼睛干涩的眼药水及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109364175A true CN109364175A (zh) | 2019-02-22 |
Family
ID=65398215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811195761.1A Pending CN109364175A (zh) | 2018-10-15 | 2018-10-15 | 一种用于缓解眼睛干涩的眼药水及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109364175A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114177202A (zh) * | 2021-12-08 | 2022-03-15 | 上海泽充生物技术有限公司 | 一种干细胞上清液滴眼液及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106427A (zh) * | 2015-08-18 | 2015-12-02 | 陈小平 | 缓解眼疲劳的眼药水及制备方法 |
CN105726768A (zh) * | 2014-12-10 | 2016-07-06 | 青岛市黄岛区中医医院 | 一种缓解眼疲劳的中药滴眼液及其制备方法 |
CN105726767A (zh) * | 2014-12-10 | 2016-07-06 | 青岛市黄岛区中医医院 | 缓解眼疲劳的中药滴眼液及其制备方法 |
-
2018
- 2018-10-15 CN CN201811195761.1A patent/CN109364175A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726768A (zh) * | 2014-12-10 | 2016-07-06 | 青岛市黄岛区中医医院 | 一种缓解眼疲劳的中药滴眼液及其制备方法 |
CN105726767A (zh) * | 2014-12-10 | 2016-07-06 | 青岛市黄岛区中医医院 | 缓解眼疲劳的中药滴眼液及其制备方法 |
CN105106427A (zh) * | 2015-08-18 | 2015-12-02 | 陈小平 | 缓解眼疲劳的眼药水及制备方法 |
Non-Patent Citations (1)
Title |
---|
CONESEQUENCEDAY: "近视宝护眼液", 《百度百科》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114177202A (zh) * | 2021-12-08 | 2022-03-15 | 上海泽充生物技术有限公司 | 一种干细胞上清液滴眼液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631558B (zh) | 一种用于治疗眼疾的中成药及其制备方法 | |
CN110170000A (zh) | 一种有助于改善视力的中药组合物及其制备方法 | |
CN108208835A (zh) | 一种黑、红枸杞复方护眼口服液及其制备方法 | |
CN100389791C (zh) | 一种滴眼液及其制备方法 | |
CN109364175A (zh) | 一种用于缓解眼睛干涩的眼药水及其制备方法 | |
CN108114084A (zh) | 一种用于提高视力的中药组合物及其制备方法 | |
CN103585363A (zh) | 一种治疗老年性白内障的中药组合物 | |
CN109078085A (zh) | 一种治疗眼疲劳干涩炎症的水凝胶药物的制备方法 | |
CN206566238U (zh) | 一种治疗白内障近视眼的中药纳米磁石熏疗片眼镜 | |
CN107412552A (zh) | 一种能够治疗儿童近视的护眼液及其制备方法 | |
CN109350683A (zh) | 一种可缓解眼睛赤热肿痛的眼药水及其制备方法 | |
CN103405609B (zh) | 一种治疗目赤翳障的中药制剂 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN104888025A (zh) | 一种治疗近视眼的中药茶包及其制备方法 | |
CN106344827A (zh) | 治疗老花眼的眼药水及其制备方法 | |
CN104689107A (zh) | 一种用于治疗近视眼的中药配方及其制备方法 | |
CN105055764A (zh) | 一种用于治疗慢性闭角型青光眼的药物 | |
CN110302357A (zh) | 一种外用明目保健中药组合物及其制备方法 | |
CN1108556A (zh) | 一种眼药水的配制方法 | |
CN104306546A (zh) | 一种用于治疗视神经萎缩的中药组合物及其汤剂、丸剂和散剂 | |
CN104706852A (zh) | 一种改善视力的中药外用药组合物及其制备方法和应用 | |
CN107802707A (zh) | 一种治疗小儿假性近视的中药组合物及其制备方法 | |
CN102626161A (zh) | 一种养眼的食品养眼茶冲剂 | |
CN109602853A (zh) | 一种治疗近视和老花眼的中药眼药水及其制备方法 | |
CN106309779A (zh) | 具有舒缓视疲劳的眼药水及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190222 |